Boston University School of Medicine (BUSM) is the lead institution on a $13.6 million study aimed at developing novel technologies for the early detection of lung cancer. The five-year multi-site, multi-phase study that will focus on active military personnel and veterans is funded by the United States Department of Defense (DOD) Lung Cancer Research Program and will be conducted under the direction of principal investigator Avrum Spira, MD, MSc, associate professor of medicine, pathology and bioinformatics at BUSM and a pulmonologist at Boston Medical Center (BMC)….

http://www.bumc.bu.edu/busm-news/2011/10/19/busm-receives-13-6m-grant-to-develop-tools-for-the-early-detection-of-lung-cancer/